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Abstract
Recent development in the data-driven decision science has seen great advances in individ-
ualized decision making. Given data with individual covariates, treatment assignments and
outcomes, policy makers best individualized treatment rule (ITR) that maximizes the expected
outcome, known as the value function. Many existing methods assume that the training and
testing distributions are the same. However, the estimated optimal ITR may have poor general-
izability when the training and testing distributions are not identical. In this paper, we consider
the problem of finding an optimal ITR from a restricted ITR class where there is some unknown
covariate changes between the training and testing distributions. We propose a novel distribu-
tionally robust ITR (DR-ITR) framework that maximizes the worst-case value function across
the values under a set of underlying distributions that are “close” to the training distribution.
The resulting DR-ITR can guarantee the performance among all such distributions reasonably
well. We further propose a calibrating procedure that tunes the DR-ITR adaptively to a small
amount of calibration data from a target population. In this way, the calibrated DR-ITR can be
shown to enjoy better generalizability than the standard ITR based on our numerical studies.
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1 Introduction
Data-driven individualized decision making problems are commonly seen in practice and have been
studied intensively in the literature. In disease management, the physician may decide whether to
introduce or switch a therapy for a patient based on his/her characteristics in order to achieve a
better clinical outcome (Bertsimas et al., 2017). In public policy making, a policy that allocates
the resource based on the characteristics of the targets can improve the overall resource allocation
efficiency (Kube et al., 2019). In a context-based recommender system, the use of the contextual
information such as time, location and social connection can increase the effectiveness of the rec-
ommendation process (Aggarwal, 2016). One common goal of these problems is to find the optimal
individualized treatment rule (ITR) mapping from the individual characteristics or contextual in-
formation to the treatment assignment, that maximizes the expected outcome, known as the value
function (Manski, 2004; Qian and Murphy, 2011).
One approach for estimating an optimal ITR is to first estimate the conditional mean outcome,
known as the Q-function, given the individual characteristics and the treatment assignment, and
then induce the ITR that prescribes the treatment by maximizing the estimated Q-function (Qian
and Murphy, 2011). In the binary treatment case, such an approach can be reformulated as esti-
mating the conditional treatment effect (CTE) as the difference of the conditional mean outcomes
under two candidate treatments (Zhao et al., 2017; Chen et al., 2017; Qi et al., 2020). Another
approach is to directly estimate the value function using the inverse-probability weighted estimator
(IPWE), and then search for the ITR that maximizes the corresponding value function (Zhao et al.,
2012; Kitagawa and Tetenov, 2018; Liu et al., 2018; Zhang et al., 2019). Since there are potential
model misspecification issues of these approaches, the augmented IPWE (AIPWE) of the value
function combines the estimates of the Q-function and the treatment propensity score. AIPWE is
doubly robust in the sense that the consistency of the value function estimate is guaranteed as long
as either the Q-function model or the propensity score model is correctly specified (Dud´ık et al.,
2011; Zhang et al., 2012b; Athey and Wager, 2017; Zhao et al., 2019a). While the doubly robust
property can protect against the violation of the model assumptions, one key assumption behind
is that the training and testing distributions should be identical.
When the training and testing distributions are different, an estimated optimal ITR may not
generalize well on the testing data (Zhao et al., 2019b). Similar phenomenon for causal inference in
randomized controlled trials (RCTs) has also been pointed out by Muller (2014); Gatsonis and Mor-
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ton (2017). Specifically, due to the inclusion and exclusion criteria of an RCT, the training sample
can be unrepresentative of the testing population we are interested in. Therefore, the corresponding
casual evidence may not be broadly applicable or relevant for the real-world practice. In causal
inference literature, it is common to regard the training data as a selected sample from the pooled
population of training and testing. The selection bias can be adjusted by reweighing or stratifying
the training data according to the relationship between training and testing (O’Muircheartaigh and
Hedges, 2014; Buchanan et al., 2018). However, it requires strong assumptions on completely mea-
suring the selection confounders and correctly specifying the selection model, and thus can only
work well on a prespecified testing population. There are many other practical scenarios where
the difference between the training and testing distributions is unknown. One example is that the
training data can be confounded by some unidentified effects such as batch effects, which may cause
potential covariate shifts (Luo et al., 2010). Another possibility is that the testing distribution may
evolve over time (Hand, 2006). There is also a widely studied scenario that multiple datasets are
aggregated to perform combined analysis (Alyass et al., 2015; Shi et al., 2018; Li et al., 2020).
Aggregating data from various sources can benefit from sharing common information, transferring
knowledge from different but related samples, and maintaining certain privacy. However, due to
the heterogeneity among data sources, standard approaches of finding pooled optimal ITRs may
not generalize well on all these sources. One way of handling the heterogeneity is to formulate it as
a problem of distributional changes, where we train on the mixture of subpopulations while testing
on one of the subpopulations (Duchi et al., 2019). In all these applications, an optimal ITR that is
robust to unattended distributional differences is of great interest.
Despite a vast literature in ITR, much less work has been done on the problem when the training
and testing distributions are different. Imai and Ratkovic (2013) and Johansson et al. (2018)
estimated the CTE function by reweighing the training loss to ensure the estimators generalizable
on a prespecified testing distribution. Zhao et al. (2019b) aimed to find an ITR that optimizes
the worst-case quality assessment among all testing covariate distributions satisfying some moment
conditions. However, since their method only requires some moment conditions, the uncertainty
set of the testing distributions can be very large. Recent developments in the distributionally
robust optimization (DRO) literature provide the opportunities to quantify the difference between
the training and testing distributions more precisely (Ben-Tal et al., 2013; Duchi and Namkoong,
2018; Rahimian and Mehrotra, 2019). Motivated by the DRO literature, we develop a new robust
optimal ITR framework in this paper.
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In this paper, we consider the problem of finding an optimal ITR from a restricted ITR class,
where there is some unknown covariate changes between the training and testing distributions.
We propose to use the distributionally robust ITR (DR-ITR) that maximizes the defined worst-
case value function among value functions under a set of underlying distributions. More specifically,
value functions are evaluated under all testing covariate distributions that are “close” to the training
distribution, and the worst-case situation takes a minimal one. Our distributionally robust ITR
framework is different from the existing doubly robust ITR framwork that uses an AIPWE. In
particular, an AIPWE robustifies the model specification assumptions, while our DR-ITR robustifes
the underlying distributions. The DR-ITR aims to guarantee reasonable performance across all
testing distributions in an uncertainty set around the training distribution by optimizing the worst-
case scenarios. In particular, we parameterize the amount of “closeness” by the distributional
robustness-constant (DR-constant), where the smallest possible DR-constant corresponds to the
standard ITR that maximizes the value function under the training distribution. To ensure the
performance of the DR-ITR on a specific testing distribution, we fit a class of DR-ITRs for a
spectrum of DR-constants at the training stage, and calibrate the DR-constant based on a small
amount of the calibrating data from the testing distribution. In this way, the correctly calibrated
DR-constant ensures that the DR-ITR performs at least as well as, often much better than, the
standard ITR. Using our illustrative example, we show that the standard ITR can have very poor
values on many testing distributions, while our calibrated DR-ITRs still maintain relatively good
performance. In particular, our proposed calibrating procedures can tune DR-constants based on
the small calibrating sample. To solve the worst-case optimization problem, we make use of the
difference-of-convex (DC) relaxation of the nonsmooth indicator, and propose two algorithms to
solve the related nonconvex optimization problems. We also provide the finite sample regret bound
for the proposed DR-ITR.
The rest of this paper is organized as follows. In Section 2, we discuss an illustrative example
that the optimality of an ITR can be sensitive to the underlying distribution, and introduce the
DR-ITR that can generalize well across all testing distributions considered in this example. Then
we propose the DR-ITR framework and the corresponding learning problem. In Section 3, we
justify the theoretical guarantees of the finite sample approximations for the learning problem.
In Section 4, we evaluate the generalizability of our proposed DR-ITR on two simulation studies:
the problem of covariate shifts and the problem of mixture of multiple subgroups. We apply our
proposed DR-ITR on the AIDS clinical dataset ACTG 175 and evaluate its generalizability on the
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subgroup of female patients in Section 5. Some related discussions and extensions are given in
Section 6. The implementation details, technical proofs and some additional numerical results are
all given in the Supplementary Material.
2 Methodology
In this section, we introduce the value maximization framework in the current literature, and
discuss its limitation when the training and testing distributions are different. Then we propose
the DR-value function that optimizes the worse-case value function across all distributions within
an uncertainty set around the training distribution.
2.1 Maximizing the Value Function
Consider the training data pX, A, Y q „ P, where X P X Ď Rp denotes the covariates, A P A “
t`1,´1u is the binary treatment assignment, and Y P Y Ď R is the observed outcome. We
assume that the larger outcome is better. Let Y p`1q, Y p´1q be the potential outcomes. Consider a
prespecified ITR class D Ď t˘1uX . For d P D, denote Y pdq :“ Y p1q1rdpXq “ 1s`Y p´1q1rdpXq “
´1s as the potential outcome following the treatment assignment prescribed by the ITR d. Then
the value function under the training distribution P is defined as
Vpdq :“ ErY pdqs.
Denote pipa|xq :“ PpA “ a|X “ xq as the training propensity score function for treatment assign-
ment. If we assume 1) the consistency of the observed outcome Y “ Y pAq; 2) the strict overlap
pip˘1|xq ě τ ą 0 for any x P X ; and 3) the strong ignorability pY p`1q, Y p´1qq K A|X (Ru-
bin, 1974), then we can identify Vpdq in terms of the observed data pX, A, Y q by the IPWE of
E
´
1rdpXq“As
pipA|Xq Y
¯
.
Instead of targeting the value function directly, we instead consider the CTE function as Cpxq :“
ErY p`1q ´ Y p´1q|X “ xs under the training distribution P. Note that for an ITR d and all
x P X , the prescribed treatment assignment satisfies dpxq P t˘1u. Then we have Cpxqdpxq “
ErY pdq ´ Y p´dq|X “ xs. Based on this representation, we define another value function
V1pdq :“ ErCpXqdpXqs “ ErY pdq ´ Y p´dqs. (1)
Since Y pdq ` Y p´dq ” Y p1q ` Y p´1q, it can be observed that V1pdq “ 2
”
Vpdq ´ ErY p`1q`Y p´1qs2
ı
“
2rVpdq ´ Vpdrandqs, where drandpxq “ `1 with probability 1{2 and ´1 with probability 1{2. There-
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fore, V1pdq can be interpreted as the value improvement of the ITR d upon the completely random
treatment rule drand. In terms of the optimal ITR, the resulting rules by optimizing the value
functions V1pdq and Vpdq over d are equivalent.
By the definition (1), we have V1pdq ď Er|CpXq|s with equality if dpXq “ signrCpXqs almost
surely. Such an ITR is the global optimal ITR when D consists of all measurable functions from
X to t˘1u. To obtain the global optimal ITR, we can estimate CpXq from data using flexible
nonparametric techniques, such as the Bayesian additive regression tree (BART) (Hill, 2011), or
the casual forest (Wager and Athey, 2018). However, in general, the global optimal ITR x ÞÑ
signrCpxqs can take a very complicated functional form, while decision makers may want to have
a simpler ITR (Kitagawa and Tetenov, 2018). Then the ITR class D is often considered as a
restricted subset of measurable functions from X to t˘1u. The following two-step procedure can
be implemented to estimate the restricted optimal ITR on D: first we estimate the CTE function
x ÞÑ pCpxq using flexible nonparametric techniques; and then we estimate the ITR by solving
maxdPD Enr pCpXqdpXqs on the restricted ITR class D (Zhang et al., 2012a). Here, En is the
empirical average based on the training data.
2.2 Covariate Changes
It can be observed that the value functions defined in Section 2.1 depend on the underlying dis-
tribution. Suppose we are interested in a testing distribution Ptest that may be different from the
training distribution P to some extent. Then ITRs estimated by most existing methods may not
be able to perform well on our target population. In order to address this problem, we first make
the following assumption on the potential difference between Ptest and P.
Assumption 1 (Covariate Changes). For every training distribution P and testing distribution
Ptest considered in this paper, we assume the followings:
(I) Ptest ! P;
(II) There exists w : X Ñ R` such that EPwpXq “ 1, and dPtest{dP “ wpXq.
Assumption 1 (I) requires that the support of the testing distribution cannot go beyond the
training distribution. Assumption 1 (II) is mathematically equivalent to assuming that the dif-
ferences between P and Ptest only appear in the covariate distributions. The treatment-response
relationship conditional on covariates remains unchanged across training and testing distributions.
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Specifically, let pXpxqpY |Xpyp1q, yp´1q|xq and qXpxqqY |Xpyp1q, yp´1q|xq be the training and test-
ing densities of the data pX, Y p1q, Y p´1qq. Then the density ratio dPtest{dP becomes
dPtest
dP
“ qXpXq
pXpXq ˆ
qY |XpY p1q, Y p´1q|Xq
pY |XpY p1q, Y p´1q|Xq .
If qY |XpY p1q, Y p´1q|Xq “ pY |XpY p1q, Y p´1q|Xq, i.e., the conditional distributions pY p1q, Y p´1qq|X
are identical under Ptest and P, then dPtest{dP “ qXpXq{pXpXq, which is the weighting function
wpXq in Assumption 1 (II).
The assumption of covariate changes is commonly seen in the setting of randomized trial.
Consider the training and testing populations together as a pooled population with finite subjects.
For each subject i P t1, 2, ¨ ¨ ¨ , Nu, let Si P t0, 1u be a selection random variable such that Si “ 1
if i is a training sample point, and Si “ 0 if i is a testing sample point. Let the distributions of
pXi, Yip1q, Yip´1qq|pSi “ 1q and pXi, Yip1q, Yip´1qq|pSi “ 0q be the training distribution P and the
testing distribution Ptest respectively. Denote sP as the joint distribution of pXi, Yip1q, Yip´1q, Siq.
Then conditions in Assumption 1 can correspond to the following (Hotz et al., 2005; Stuart et al.,
2011):
• (Overlapping Support) 0 ă sPpSi “ 1|Xiq ă 1;
• (Selection Unconfoundedness) Si K pYip1q, Yip´1qq|Xi.
In particular, under this finite population setting, the overlapping support condition is equivalent
to that Ptest ! P and P ! Ptest, and the selection unconfoundedness condition is equivalent to
Assumption 1 (II). Such a correspondence can bring more intuitive implications of Assumption
1 under the randomized trial setting. Specifically, the overlapping support requires the chances
of each subject being selected into the training and testing populations to be both positive. The
selection unconfoundnedness requires that the selection mechanism is independent of the potential
outcomes given the covariates. Both conditions can be satisfied by a successful trial design (Pearl
and Bareinboim, 2014). The phenomenon of covariate changes between P and Ptest can exist ifsPpSi “ 1|Xiq ‰ sPpSi “ 0|Xiq with a positive probability. This can be often the case if the subject
needs to satisfy certain requirements before enrolling a trial.
As a consequence from Assumption 1, the CTE function CpXq “ EPrY p1q ´ Y p´1q|Xs “
EtestrY p1q´Y p´1q|Xs remains unchanged under P and Ptest. Then it can be convenient to consider
the value functions V1pdq “ EPrCpXqdpXqs and V1,testpdq “ EtestrCpXqdpXqs defined in (1).
When the testing value function V1,testpdq is of interest, maximizing the training value function
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V1pdq may not be optimal. Alternatively, we can rewrite the testing value function V1,testpdq “
EPrwpXqCpXqdpXqs where wpXq “ dPtest{dP. Then based on the training data from P, we can
maximize EPrwpXqCpXqdpXqs that targets the correct objective. It amounts to determine the
weighting function w that captures the differences between Ptest and P.
Remark 1. Notice that for any weighting function w : X Ñ R`, we have EPrwpXqCpXqdpXqs ď
EPrwpXq|CpXq|s with equality if dpXq “ signrCpXqs. That is, if D consists of all measurable
functions from X to t˘1u, then the global optimal ITR is not sensitive to any covariate changes
in the testing distribution. However, the problem of covariate changes induces a challenge if D is
a restricted ITR class.
Remark 2. Our methodology only relies on the fact that CpXq remains unchanged under P and
Ptest. Therefore, it can be possible to relax Assumption 1 to allowing distributional changes in
pY p1q, Y p´1qq|X, while assuming that the CTE function Cp¨q remains identical across P and Ptest.
Furthermore, our methodology can also be meaningful if the testing CTE function can be different
from training, but the optimal treatment assignment remains unchanged. We will discuss this
extension in Remark 5.
2.3 An Illustrative Example
In this section, we begin with an example as in Figure 1 that the optimality of an ITR depends
on the underlying distribution. There are two underlying bivariate normal distributions of means
p0, 0qᵀ (training) and p1.47, 1.69qᵀ (testing) respectively. We obtain the standard ITR by max-
imizing the value function V1pdq under the training distribution over the linear ITR class. We
also obtain the DR-ITR by maximizing the DR-value function Vkc pdq to be introduced in Section
2.4 over the linear ITR class. Then the DR-ITR is compared with the standard ITR through
the value functions V1 under the training distribution and V1,test under the testing distribution
as in Table 1. Since the values can be comparable only through the same value function but
not across different value functions, we further define the criteria relative regret of an ITR as
rvaluepLB-ITRq´valuepITRqs{|valuepLB-ITRq|, where “value” can be V1 or V1,test, and the LB-ITR
maximizes the corresponding value function over the linear ITR class. In this sense, value(LB-ITR)
is the best achievable value among the linear ITR class for the corresponding value function, and
becomes the benchmark reference for the relative regret criteria.
Two facts can be concluded from Table 1: 1) the optimality of an ITR can be different across
7
−2
0
2
4
−2 0 2 4
X1
X 2
type DR−ITR Standard ITR
domain Testing Training The DR−ITR Outperforms the Standard ITR The DR−ITR Underperforms the Standard ITR
Training mean = (0, 0), testing mean = (1.47, 1.96)
Comparing the DR−ITR (k = 2, c = 20) and the Standard ITR on the Training and Testing 95% Confidence Ellipsoids
Figure 1: ITRs and the 95% confidence ellipsoids of the training distribution pX1, X2q „ N2
`p0, 0qᵀ, I2˘
and the testing distribution pX1, X2q „ N2
`p1.47, 1.96qᵀ, I2˘. The blue dashed curve is the underlying CTE
boundary CpX1, X2q “ X2 ´ pX31 ´ 2X1q “ 0.
Table 1: Testing Values (Relative Regrets) Comparisons of ITRs
Value
ITR
DR-ITR Standard ITR LB-ITR
Training V1 0.6253 (37.36%) 0.9982 (0%) 0.9982
Testing V1,test 4.8230 (9.16%) 0.2927 (94.49%) 5.3096
1 DR-ITR maximizes Vkc pdq defined in (4) with k “ 2 and c “ 20 over the linear
ITR class.
2 Standard ITR maximizes V1pdq over the linear ITR class.
3 LB-ITR maximizes V1pdq or V1,testpdq over the linear ITR class.
4 Values (larger the better) can be comparable within rows but incomparable
between rows.
5 Relative regretpITRq “ rvaluepLB-ITRq´valuepITRqs{|valuepLB-ITRq| (smaller
the better).
6 A size-10,000 sample is generated for fitting DR-ITR and LB-ITRs, and an
independent size-100,000 sample is generated for evaluation under V1 and V1,test.
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different distributions; and 2) maximizing the training value function may have poor testing per-
formance when covariate changes exist. In Table 1, even though the standard ITR is optimal under
the training distribution, it can be far from optimal (94.49% off in terms of relative regret) under
the testing distribution. In contrast, the DR-ITR may not enjoy high training value, but can have
much better testing performance (only 9.16% off in terms of relative regret).
Remark 3. Figure 1 also illustrates how the covariate changes affect the optimality of ITRs.
Specifically, we can divide the covariate domain into two types of subdomains, annotated in blue
and red, on which the DR-ITR and standard ITR have different treatment assignments. On the
blue subdomain, the standard ITR assignment shares the same sign with the CTE function, while
the DR-ITR does not. In this case, the standard ITR outperforms the DR-ITR with the difference
of value |CpXq| at the individual level. The case reverses on the red subdomain on which the
DR-ITR outperforms the standard ITR. The overall difference of values integrates the individual
difference with respect to the training or testing density.
The overall outperformance of the DR-ITR under the testing distribution can be explained from
the following three perspectives: 1) the 95% confidence ellipsoid of the training domain only covers
a small area of the red subdomain, while that of the testing domain covers a much larger area; 2) the
distance of the red subdomain from the testing centroid is much closer than its distance from the
training centroid. Then the red subdomain concentrates higher testing density than training; and
3) the individual value differences |CpXq|’s are generally larger on the red subdomain intersected
with the testing domain than that intersected with the training domain. Therefore, the DR-ITR
performs much better than the standard ITR on the testing distribution.
2.4 Maximizing the Distributionally Robust Value (DR-Value) Function
We begin to introduce our DR-ITR that can show strong generalizability as in Figure 1. As
discussed in Section 1, our goal in this paper is not to find an ITR that is generalizable on a
specific testing distribution, but rather, to find an ITR that guarantees reasonable performance
across an uncertain set of testing distributions. We first define the k-th power uncertainty set in
two equivalent ways under Assumption 1:
Pkc pPq : “
!
Q ! P
ˇˇˇ
}dQ{dP}LkpPq ď c
)
(2)
“
"
Q ! P
ˇˇˇˇ
w : X Ñ R`, EPwpXq “ 1, EPwpXqk ď ck, dQ
dP
“ wpXq
*
. (3)
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The set Pkc pPq consists of the probability distributions Q such that the LkpPq-norm of the density
ratio dQ{dP is bounded above by the DR-constant c. The definition (3) highlights that the density
ratio is a weighting function w of X, and the distribution Q in Pkc pPq can be characterized by
the weighting function w satisfying the conditions in (3). Here the DR-constant c ě 1 controls
the degree of the distributional robustness that measures how “close” Q is from P. In particular,
c “ 1 reduces the power uncertainty set Pk1 pPq to the singleton tPu. The power order 1 ă k ď `8
parametrizes the measurement of the distance of Q from P. In particular, the power uncertainty
set Pkc pPq increases in c as k is fixed, and decreases in k as c is fixed. The latter one is due
to the Lyapunov’s inequality: }dQ{dP}LkpPq ď }dQ{dP}Lk1 pPq whenever 1 ă k ď k1 ď `8. In
the Supplementary Material, we will discuss the explicit form of Pkc pPq in the context of specific
parametric families of distributions, and how it depends on the DR-constant c and the power k.
One important conclusion from Example S.2 in the Supplementary Material for the mean-shifted
p-dimensional normal distribution is that Nppµ, Ipq P Pkc
`Npp0p, Ipq˘ if and only if }µ}22 ď 2 log ck´1 .
With the power uncertainty set Pkc pPq, we propose to robustly maximize the following worst-case
value function among the values under Q P Pkc pPq:
Vkc pdq :“ inf
QPPkc pPq
EQrCpXqdpXqs, (4)
which we term as the DR-value function. In particular, c “ 1 reduces the DR-value function Vk1 pdq
to the standard value function V1pdq “ EPrCpXqdpXqs in the definition (1).
Remark 4 (Optimality). The “optimality” of the DR-ITR is with respect to the DR-value function
Vkc , which highlights its difference from the traditional “optimal” ITR with respect to the standard
value function V1.
In the example in Section 2.3, the standard ITR maximizes the value function under the training
distribution over the linear ITR class, while the DR-ITR maximizes the DR-value function Vkc pdq
of k “ 2 and c “ 20 over the linear ITR class. In particular, the randomness of P comes from the
training covariate distribution N2p02, I2q. Such a choice of Pkc pPq contains the mean-shifted normal
distributions N2pµ, I2q for all µ P
 pµ1, µ2qᵀ : µ21 ` µ22 ď 4 log 5(. In Figure 2a, we enumerate such
mean-shifted normal distributions as the testing distributions, and evaluate the relative improve-
ment of the DR-ITR over the standard ITR as the difference of their relative regrets. Among
all testing distributions, the relative improvements of the DR-ITR span from ´37.4% to 85.3%,
suggesting that the potential of improvement can be large. Besides the DR-constant c “ 20, we
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also consider the case c “ 2.71, 6.51, 10.31 in the Supplementary Material. As c increases, the range
of relative improvements becomes wider. The increase in the relative improvement upper bound is
in general much larger than the decrease in the lower bound.
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Relative Value Improvements of the DR−ITR (c = 20) over
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(a) c “ 20
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Relative Value Improvements of the DR−ITR (ncalib = 50) over
the Standard ITR on the (µ1, µ2)−Mean Testing Distributions
Relative value improvements range in [−1.70%, 82.4%].
(b) Calibrating c on a size-50 Sample
Figure 2: Relative improvements of the DR-ITR over the standard ITR as the difference of relative regrets
on testing distributions N2
`
µ, I2
˘
of µ P  pµ1, µ2qᵀ P R2 : µ21 ` µ22 ď 4 log 5( (lighter the better).
Based on these observations, the DR-constant c should be carefully chosen. On one hand, as
can be seen from Figure 2a, the DR-ITR for a fixed DR-constant c may or may not improve over
the standard ITR on a specific testing distribution within Pkc pPq. When the DR-constant c can
be tuned adaptive to the specific testing distribution, then the DR-ITR can perform at least as
well as the standard ITR. On the other hand, we may not even have any prior information on c
to ensure that the power uncertainty set Pkc pPq contains the testing distribution of interest. Both
cases ask for additional information to calibrate the choice of c so that the DR-ITR performs well
on a specific testing distribution. Suppose we are able to obtain a small size of calibrating sample
from the testing distribution. We propose the following training-calibrating procedure to choose
c: 1) at the training stage, we estimate DR-ITRs tpdcucPC where c is the DR-constant to computepdc, and C is a set of candidate DR-constants; 2) we obtain a calibrating sample from the testing
distribution, on which we estimate the testing values of tpdcucPC ; 3) we select the pc that maximizes
the value of pdc among c P C.
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In order to estimate the value function under the testing distribution, we consider the following
two possible calibration scenarios: 1) the calibrating sample is a randomized controlled trial (RCT)
dataset pX, A, Y q from the testing distribution; and 2) the calibrating sample only consists of the
covariates X from the testing distribution. Scenario 1 will be more ideal than Scenario 2 since
we have the testing information of both the treatment and the outcome. We can evaluate an ITR
d using the IPWE pVIPWEcalib pdq “ Encalibt1rdpXq “ AsY {picalibpA|Xqu, where Encalib is the empirical
average over the calibrating sample, picalib is the corresponding propensity score function, and picalib
is known or estimable from the calibrating data. We call the corresponding calibrate DR-ITR as
RCT-DR-ITR. In Scenario 2, we do not have the treatment-response information from the testing
distribution. We can instead use the value function estimate pVCTEcalib pdq “ Encalibr pCnpXqdpXqs to
evaluate d, where pCnpXq is estimated at the training stage. However, the CTE estimate pCnp¨q may
also suffer from a potential generalizability problem on the testing distribution. Practitioners need
to be careful of the generalizability of the CTE estimate when performing the calibration. We call
the corresponding DR-ITR as CTE-DR-ITR.
RCT-DR-ITR and CTE-DR-ITR are different in their use of information for calibration. Specif-
ically, the RCT-DR-ITR makes use of pX, A, Y q from the testing distribution, while the CTE-DR-
ITR only makes use of X from the testing distribution, and the underlying CTE function CpXq. In
practice, CpXq is estimated from training data. It requires Assumption 1 to generalize the CTE es-
timate pCnpXq from training to testing. If Assumption 1 holds, then CTE-DR-ITR can have better
performance than RCT-DR-ITR, since CTE-DR-ITR captures less variance from calibrated data.
If Assumption 1 is violated, which will be illustrated in Section 4.2, then CTE-DR-ITR can have
poorer performance than RCT-DR-ITR, since the testing value function estimate of CTE-DR-ITR
can be biased.
In Figure 2b, we generate a calibrating RCT sample from Ptest of size 50. It shows that across
the mean-shifted testing distributions, the relative improvements of the calibrated DR-ITRs range
from ´1.70% to 82.4%. It suggests that the small sample size 50 is sufficient for a reasonably good
calibration, with the positive relative improvements being maintained.
Remark 5 (Extending Covariate Changes). Consider the case that Assumption 1 is violated. Let
Ctest be the testing CTE function that can be different from the training CTE function C. We use
the notations P and Ptest to refer to the training and testing covariate distributions. Assume that
signrCtestpXqs “ signrCpXqs almost surely. Then we can still represent the value function under
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the testing distribution as follows:
EtestrCtestpXqdpXqs “ EP
"
dPtest
dP
CtestpXq
CpXq 1rCpXq ‰ 0s ˆ CpXqdpXq
*
.
The definition of the DR-value function (4) can be robust with respect to the change of pPtest, Ctestq
from pP, Cq, such that wpXq :“ pdPtest{dPq ˆ rCtestpXq{CpXqs1rCpXq ‰ 0s satisfies EPwpXq “ 1
and EPwpXqk ď ck.
Remark 6. The calibration procedure ensures that among the DR-ITRs of various DR-constants,
the best one is chosen to maximize the testing value function. In this sense, the calibrated DR-ITR
can have potential of improving the generalizability from training to testing. However, if the testing
distribution is very far from the training distribution, one cannot expect that an ITR estimated by
any method from the training data can perform well on the test data, even though our proposed
method may be able to protect against such a distributional change to some extent. Therefore, in
practice, we suggest to use our method when training and testing distributions are relatively close.
2.5 Distributionally Robust Expectation
In this section, we first discuss the rationale of considering the Lk-norm of the density ratio as
the measurement of distributional distance. We show that the k-th power uncertainty set Pkc pPq
is equivalent to the distributional ball induced by the φ-divergence (Pardo, 2005) for some specific
divergence φ. Then we derive the dual form of the worst-case expectation over Pkc pPq, which
provides a more tractable optimization problem.
2.5.1 Equivalence to the Divergence-Based Distributional Ball
As a generalization of the conventional likelihood-based framework which corresponds to the Kullback-
Leibler (KL) divergence, the framework of general φ-divergence between distributions has been
well studied in the context of parameter estimation and hypothesis testing (Pardo, 2005). The
φ-divergence between two probability distributions P and Q such that Q ! P is defined as follows:
DφpQ}Pq :“
ż
φ
ˆ
dQ
dP
˙
dP “ EPφ
ˆ
dQ
dP
˙
; φ P Φ,
where Φ is a class of convex functions on R that satisfies the regularity conditions: φpwq “ `8
for w ă 0, φp1q “ φ1p1q “ 0, and lim
wÑ0`
wφpp{wq “ lim
wÑ`8φpwq{w for p ą 0. The definition
with various choices of φ’s includes the empirical likelihood φELpwq “ ´ logw ` w ´ 1, the KL
divergence φKLpwq “ w logw ´ w ` 1, and the χ2-divergence φχ2pwq “ 12pw ´ 1q2. There is
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another important special case that relates to the power uncertainty set of k “ `8. Consider the
optimization indicator for c ě 1: φ8,c “ 0 if u P r0, cs and `8 otherwise, for which Dφ8,cpQ}Pq “
0 if }dQ{dP}L8pPq ď c, and `8 otherwise. Then Dφ8,cpQ}Pq “ 0 if and only if Q P P8c pPq.
Although Dφ is not a proper metric between probability distributions since it is asymmetric, we
can still define a Dφ-distributional ball as P
φ
ρ pPq :“ tQ ! P : DφpQ}Pq ď ρu, where P is the center
and ρ ě 0 is the radius. Then for any ρ ě 0, the Dφ8,c-distributional ball Pφ8,cρ pPq ” tQ ! P :
Dφ8,cpQ}Pq “ 0u, which coincides with the power uncertainty set P8c pPq defined in (2) for k “ 8.
Such an equivalence can be extended to all finite k P p1,`8q when a Cressie-Read (CR) family
(Cressie and Read, 1984) of divergence functions ΦCR Ď Φ is taken into consideration. For k ą 1,
the corresponding φk P ΦCR is defined as
φkpwq :“ w
k ´ kw ` k ´ 1
kpk ´ 1q ; w ě 0.
Here, φk effectively measures the probability-distributional distance by the k-th moment of the
density ratio, since DφkpQ}Pq “ 1kpk´1q rEPpdQ{dPqk ´ 1s as long as Q is a probability distribution.
Then it can be inferred that the Dφk -distributional ballP
φk
ρ pPq is actually equivalent to the power
uncertainty set PkckpρqpPq in (2). Here, there is a one-to-one correspondence between the DR-
constant c and the radius ρ of the Dφk -distributional ball with ckpρq :“ rkpk ´ 1qρ ` 1s1{k. We
conclude the case k “ `8 and 1 ă k ă `8 with the following:
P
φ8,c
ρ pPq “ P8c pPq; Pφkρ pPq “ PkckpρqpPq; ρ ě 0. (5)
2.5.2 Dual Representation
We begin with a general result on the dual representation of the φ-divergence-based distributionally
robust expectation. We state the following lemma and refer readers to Duchi and Namkoong (2018,
Proposition 1).
Lemma 1. Fix a random variable Z on R with distribution P. Let φ P Φ be a legitimate divergence
function. Define the convex conjugate of φ as
φ‹px‹q :“ sup
xPR
txx‹, xy ´ φpxqu; x‹ P R.
Then for ρ ą 0,
sup
QPPφρ pPq
EQZ “ inf
λě0
ηPR
"
EP
„
λφ‹
ˆ
Z ´ η
λ
˙
` λρ` η
*
. (6)
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Let c ě 1. Lemma 1 can be directly applied to the optimization indicator: φ8,cpuq :“ 0 if
u P r0, cs and `8 otherwise, whose convex conjugate is given by φ‹8,cpuq “ cmaxtu, 0u. Then λ in
(6) attains the infimum at λ “ 0, so that
sup
QPPφ8,cρ pPq
EQZ “ inf
ηPR tcEPpZ ´ ηq` ` ηu . (7)
In particular, the right hand side of (7) is solved by the p1´ 1{cq-value-at-risk VaR1´1{c in finance,
or equivalently, the p1´ 1{cq-quantile of Z under the center distribution P. The right hand side of
(7) itself is defined as the p1´ 1{cq-conditional value-at-risk CVaR1´1{c (Rockafellar and Uryasev,
2000). Next, we apply Lemma 1 to the k-th power divergence φk to derive the dual problem of the
worst-case expectation over Pkc pPq.
Lemma 2. Let ΦCR be the Cressie-Read family of divergence functions, k, k
‹ P p1,`8q be conjugate
numbers, i.e., 1k ` 1k‹ “ 1, and φk P ΦCR. Then we have following conclusions:
(I) The convex conjugate of φk is given by
φ‹kpzq “ 1k
!
rpk ´ 1qz ` 1sk‹` ´ 1
)
.
(II) Fix a probability measure P and a random variable Z on R. Then for ρ ě 0,
sup
QPPφkρ pPq
EQZ “ inf
ηPR
!
ckpρqrEPpZ ´ ηqk‹` s1{k‹ ` η
)
, (8)
where ckpρq “ rkpk ´ 1qρ` 1s1{k.
Note that the right hand side of (8) and its optimizer η are both coherent risk measures as the
higher-order generalizations of the CVaR and VaR (Krokhmal, 2007).
Using the equivalence in (5), the worst-case expectation over the power uncertainty set Pkc pPq
for k P p1,8s and k‹ “ kk´1 (in particular, k “ 8 ô k‹ “ 1) unifies (7) and (8) as follows:
sup
QPPkc pPq
EQZ “ inf
ηPR
!
crEPpZ ´ ηqk‹` s1{k‹ ` η
)
; c ě 1. (9)
By inspecting the dual problem (9), the right hand side is computationally more tractable than the
left hand side, since instead of optimizing over an infinite-dimensional probability measure Q, we
only need to optimize over a univariate variable η.
In order to apply the duality result to the DR-ITR problem, we negate the DR-value maximiza-
tion to a risk minimization problem. Denote the risk function under the training distribution P as
15
R1pdq :“ ´V1pdq “ EPtCpXqr´dpXqsu. Then for k P p1,`8s and c ě 1, the DR-risk function is
defined as
Rkc pdq :“ sup
QPPkc pPq
EQtCpXqr´dpXqsu.
Using the fact Z “ ´CpXqdpXq “ CpXq1rdpXq “ ´1s ` r´CpXqs1rdpXq “ 1s, the dual repre-
sentation (9) can be expressed in the following particular form (10).
Corollary 3 (Dual Representation of the DR-Risk Function). Let k P p1,`8s, k‹ “ kk´1 if k ă `8
and k‹ “ 1 if k “ `8, c ě 1. Then the DR-risk function Rkc has the following dual representation:
Rkc pdq “ inf
ηPR
"
c
”
E
´
rCpXq ´ ηsk‹` 1rdpXq “ ´1s ` r´CpXq ´ ηsk‹` 1rdpXq “ 1s
¯ı1{k‹ ` η* . (10)
2.6 Implementation
In this section, we introduce the implementation of DR-risk minimization based on the empirical
data. We cast the learning problem as finding a decision function f : X Ñ R that induces an ITR
based on its sign: dpxq “ signrfpxqs. The ITR class D can correspond to a prespecified decision
function class F . The DR-risk function as a functional of the decision function becomes Rkc pfq “
supQPPkc pPq EQ
 
CpXqsignr´fpXqs(. However, directly optimizing the risk Rkc pfq is challenging,
since the signp¨q operation is nonconvex and nonsmooth. We consider a specific difference-of-
convex (DC) relaxation of the sign operator.
We propose to relax the indicators in the dual form (10) by the following robust smoothed ramp
loss (Zhou et al., 2017): ψpuq :“ p1´uq21p0 ď u ď 1q` r2´p1`uq2s1p´1 ď u ď 0q` 21pu ď ´1q.
The DC representation is given by ψpuq “ ψ`puq ´ ψ´puq, where ψ`puq “ p1 ´ uq21p0 ď u ď
1q ` p1´ 2uq1pu ď 0q, ψ´puq “ u21p´1 ď u ď 0q ` p´1´ 2uq1pu ď ´1q. The advantages of using
the symmetric nonconvex loss can be: 1) to protect from outliers in X and improve generalizability
(Shen et al., 2003; Wu and Liu, 2007), and 2) to equally indicate fpXq ă 0 and fpXq ą 0. We would
like to point out that 1rfpXq ă 0s ` 1rfpXq ą 0s ” 1 will be preserved to ψrfpXqs2 ` ψr´fpXqs2 ” 1
in this surrogate loss. Then we define the DR-ψ-risk function as
Rkc,ψpfq :“ inf
ηPR
#
c
„
E
ˆ
rCpXq ´ ηsk‹` ψrfpXqs2 ` r´CpXq ´ ηs
k‹`
ψr´fpXqs
2
˙1{k‹
` η
+
. (11)
Algebraically, we can invert (11) to its primal representationRkc,ψpfq “ supQPPkc pPq EQrCpXqζψpfqs
by introducing a sign random variable ζψpfq P t˘1u with Ppζψpfq “ ˘1|Xq :“ ψr˘fpXqs2 . That is,
given the covariate X, the original deterministic sign signr´fpXqs is relaxed to the random sign
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ζψpfq with ˘1 probability ψr˘fpXqs2 . In particular, if fpXq ą 0, then signr´fpXqs “ ´1 is a hard
sign while ζψpfq is a soft sign with Ppζψpfq “ ´1|Xq “ ψr´fpXqs2 ą ψrfpXqs2 “ Ppζψpfq “ 1|Xq.
When c “ 1, the DR-risk function reduces to the risk function under the training distribution, and
the DC relaxation here is equivalent to the relaxation in Zhou et al. (2017).
The DR-ψ-risk function provides the learning objective based on the empirical data. In partic-
ular, the population expectation E is replaced by the empirical average En, and the CTE function
Cp¨q is replaced by a plug-in estimate pCnp¨q. The corresponding empirical objective is minimized
over the decision function f and the auxiliary variables pη, λq jointly:
min
fPF ,ηPR
#
c
„
En
ˆ
r pCnpXq ´ ηsk‹` ψrfpXqs2 ` r´ pCnpXq ´ ηsk‹` ψr´fpXqs2
˙1{k‹
` η
+
“ min
fPF ,ηPR,λě0
"
c
k‹λk‹´1En
ˆ
r pCnpXq ´ ηsk‹` ψrfpXqs2 ` r´ pCnpXq ´ ηsk‹` ψr´fpXqs2
˙
` cλ
k
` η
*
.
The objective function is a summation of multiple products of DC functions. For k ă `8, we
consider a block successive upper-bound minimization algorithm (Razaviyayn et al., 2013) to alter-
natively minimize the convex upper bounds over the decision function f and the auxiliary variables
pη, λq respectively. For k “ `8, it requires a further probabilistic enhancement to break ties at
argmin and ensure the convergence to stationarity (Qi et al., 2019a,b). The implementation details
are given in the Supplementary Material.
3 Theoretical Properties
In this section, we justify the validity of the DC relaxation and the empirical substitution. First of
all, we introduce the following joint stochastic objectives:
`kc pf, η, λ; rCq :“ ck‹λk‹´1 ´r rCpXq ´ ηsk‹` 1rfpXq ă 0s ` r´ rCpXq ´ ηsk‹` 1rfpXq ą 0s¯` cλk ` η;
`kc,ψpf, η, λ; rCq :“ ck‹λk‹´1
ˆ
r rCpXq ´ ηsk‹` ψrfpXqs2 ` r´ rCpXq ´ ηsk‹` ψr´fpXqs2
˙
` cλ
k
` η.
Here, rC can be the plug-in estimate pCn or the underlying true CTE C. Denote Lkc pf, η, λq :“
E`kc pf, η, λ;Cq, Lkc,ψpf, η, λq :“ E`kc,ψpf, η, λ;Cq. Then by Corollary 3, we haveRkc pfq “ infηPR,λě0 Lkc pf, η, λq,
Rkc,ψpfq “ infηPR,λě0 Lkc,ψpf, η, λq. In the following proposition, we show the validity of the DC re-
laxation.
Proposition 4 (Fisher Consistency and Excess Risk). Suppose Rkc , Rkc,ψ, Lkc and Lkc,ψ are defined
as above. Fix k P p1,`8s, k‹ “ kk´1 , c ě 1, η P R, λ ą 0. Then the following results hold:
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(I) (Fisher Consistency)
argmin
f :XÑr´1,1s
Lkc,ψpf, η, λq “ argmin
f :XÑt˘1u
Lkc pf, η, λq, min
f :XÑr´1,1s
Lkc,ψpf, η, λq “ min
f :XÑt˘1u
Lkc pf, η, λq;
(II) (Excess Risk) Denote Lk,˚c pη, λq :“ minfPXÑt˘1u Lkc pf, η, λq. Then for f : X Ñ R, we have
Lkc pf, η, λq ´ Lk,˚c pη, λq ď 2rLkc,ψpf, η, λq ´ Lk,˚c pη, λqs.
Denote Rk,˚c :“ infηPR,λě0 Lk,˚c pη, λq. Then for f : X Ñ R, we have
Lkc pf, η, λq ´Rk,˚c ď 2rLkc,ψpf, η, λq ´Rk,˚c s, Rkc pfq ´Rk,˚c ď 2rRkc,ψpfq ´Rk,˚c s.
Suppose F is a functional class on X with norm } ¨ }F that characterizes the complexity of
function. Motivated by Steinwart and Scovel (2007, (6)), we define for γ ě 0 the constrained
version of the approximation error
Akc pγq :“ inf
fPF
!
Rkc,ψpfq : }f}F ď γ
)
´Rk,˚c .
Similarly to that in Steinwart and Scovel (2007), Akc pγq with the appropriately chosen tuning
parameter γ can trade off the learnability and the approximatability of F towards the population
Bayes rule argminf :XÑt˘1uRkc pfq. Specifically, as γ increases, the population approximation error
(“bias”) Akc pγq decreases with γ, while the empirical complexity (“variance”) increases with γ. The
trade-off will be stated more explicitly in the following Assumption 5.
Next, we make the following assumptions to show the regret bound for the empirical mini-
mization of the ψ-risk En`kc,ψpf, η, λ; pCnq. Without loss of generality, we restrict to consider the
functional class F as the Reproducing Kernel Hilbert Space (RKHS) with the Gaussian radial basis
function kernels, where } ¨ }F is the RKHS-norm. General results can be established by adopting
the covering number argument as in Zhao et al. (2019a, Theorem 3.1).
Assumption 2 (Boundedness). There exists M ă `8 such that |CpXq| ďM almost surely.
Assumption 3 (Diffuse Property). The distribution of CpXq has a uniformly bounded density
with respect to the Lebesgue measure.
Assumption 4 (Convergence of the Plug-in CTE). For the CTE estimate pCnpXq, we assume that
} pCn ´ C}8 :“ sup
xPX
ˇˇˇ pCnpxq ´ Cpxqˇˇˇ PÑ 0.
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Assumption 5 (Approximation Error Rate). There exists β P p0, 1s and KA ă `8 such that for
all small enough γ ą 0, we have Akc pγq ď KAγ´β.
As a remark, we note that Assumption 2 can hold if the difference of potential outcomes
Y p1q ´ Y p´1q is uniformly bounded, or X is compact and x ÞÑ Cpxq is continuous. Assumption
3 holds if X has a diffuse distribution, i.e., X doesn’t contain points with positive mass; and
x ÞÑ Cpxq is injective. Assumption 3 is the key assumption to bound λ away from 0. This
assumption will not be necessary if k “ `8 and k‹ “ 1. Assumption 4 can be met if X is compact
and pCn is a random forest estimate (Wager and Walther, 2015). Following Steinwart and Scovel
(2007, Theorem 2.7), Assumption 5 can be shown valid if the Tsybakov’s noise assumption on the
population margin is met and the kernel bandwidth parameter is chosen appropriately. In the
following proposition, we establish the regret bound.
Proposition 5 (Regret Bound). Suppose Rkc , Rkc,ψ, Lkc and Lkc,ψ are defined as above. Fix k P
p1,`8s, k‹ “ kk´1 , c ą 1. Assume that Assumptions 2-5 hold. Let
p pfn, pηn, pλnq P argmin
fPF ,ηPR,λě0
!
En`kc,ψpf, η, λ; pCnq : }f}F ď γn) ,
with the tuning parameter γn satisfying γn “ Opn´
1
2β`1 q as n Ñ 8. Then there exists constants
K0 “ K0pc,Mq ă `8 and K1 “ K1pc,Mq ă `8 such that for 0 ă δ ă 1, with probability at least
1´ δ, we have
Rkc p pfnq ´Rk,˚c ď Lkc p pfn, pηn, pλnq ´Rk,˚c ď K0alogp2{δqn´ β2β`1 `K1} pCn ´ C}8.
In particular, there exists K01,K02,K11,K12 ă `8 not depending on c,M , such that
K0pc,Mq “
$’&’%K01
c
pk‹`1qp2k‹´1q
k‹´1 `
1
2
pc´1qk‹`1{2 M
k‹`1{2, k ă `8;
K02cM
3{2, k “ `8;
K1pc,Mq “
$’&’%K11
c2k
‹`1
pc´1qk‹´1M
k‹´1, k ă `8;
K12c, k “ `8.
In Proposition 5, it can be of theoretical interest to understand how the regret bound depends
on the DR-constant c and the power order k. Specifically, as cÑ `8, η approaches to the essential
supremum of rCpXq´ηsk‹` ψrfpXqs2 `r´CpXq´ηsk
‹
`
ψr´fpXqs
2 (Krokhmal, 2007, Example 2.3). Then
λ vanishes to 0 so that 1{λ tends to `8. Since the Lipschitz constant of `kc,ψpf, η, λq with respect
to λ scales with 1{λk‹ , the universal constants K0 and K1 grow to `8 as well.
Another important fact is that the conjugate number k‹ of k appears in the polynomial orders
of c and M respectively in the universal constants K0 and K1. In particular, for a large conjugate
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order k‹, the universal constants K0 and K1 increase with the DR-constant c and the CTE bound
M more rapidly. In order to achieve a tighter finite sample regret bound, a smaller k‹ and hence
a larger k is preferred. Such a phenomenon complements the fact that the power uncertainty set
Pkc pPq decreases in k. Specifically, as the power order k increases, its conjugate order k‹ decreases,
and the regret bound in Proposition 5 becomes tighter. On the contrary, the power uncertainty
set Pkc pPq gets smaller, and the worst-case objective is less distributionally robust. Therefore, the
power order k trades off between the distributional robustness in terms of the size of Pkc pPq, and
the finite sample regret bound.
4 Simulation Studies
In this section, we carry out two simulation studies to evaluate the generalizability of the DR-ITR
on the testing distributions that are different from the training distribution. The first simulation
considers the covariat shifts. The second simulation considers the mixture of subgroups.
4.1 Covariate Shifts
In this section, we extend the motivating example in Section 2.3 to a more practical simulation
setting. Consider the training data generating process: n “ 1, 000, p “ 10, X „ Npp0p, Ipq, A|X „
Bernoullip1{2q and Y |pX, Aq “ mpXq ` pA´ 1{2qCpXq `N p0, 1q, where mpxq “ 1` 1p
řp
j“1 xj ,
Cpxq “ x2 ´ px31 ´ 2x1q.
At the training stage, we first obtain a CTE function estimate pCn by fitting a casual forest (Wa-
ger and Athey, 2018) on the training data. Then we obtain the out-of-bag prediction at the training
covariates pCnpXq. Next we fit the standard ITR by empirically minimizing En pCnpXq pψrfpXqs ´ 1q (
as the ψ-relaxation of the empirical risk function En
 pCnpXqsignr´fpXqs(, over the linear func-
tion class Fγ :“ tfpxq “ b ` βᵀx : b P R, β P Rp, }β}2 ď γu. The tuning parameter γ ě 0
is determined by 10-fold cross-validation among t0.1, 0.5, 1, 2, 4u. Finally, we fit the DR-ITRs for
k “ 2 and c P C “ t1.19, 1.38, ¨ ¨ ¨ , 20u from the function class Fγ , where γ is the same as that of
the standard ITR.
We consider the mean-shifted testing distribution X „ Nppµ, Ipq for various covariate centroids
µ’s. In order to calibrate the DR-constant c for every fixed µ, we generate a calibrating dataset of
size ncalib “ 50 from the testing distribution. The following two scenarios for the calibrating data
are considered here: 1) a randomized controlled trial (RCT) dataset pX, A, Y q is generated, with
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X „ Nppµ, Ipq and pA, Y q as before; and 2) only the covariate vector X „ Nppµ, Ipq is generated.
In Scenario 1, we use the IPWE of the calibrating value function pVIPWEcalib p pfcq :“ EncalibtY 1rp2A ´
1q pfcpXq ą 0s{p1{2qu to evaulate the DR-constant c, while in Scenario 2, we use the CTE-based
calibrating value function pVCTEcalib p pfcq :“ Encalibt pCnpXqsignr pfcpXqsu instead. Here, the estimated
CTE function pCn is obtained from the training stage.
For comparison, we consider the following: 1) the LB-ITR that maximizes the value func-
tion under the testing distribution; 2) the `1-penalized least-square (`1-PLS) (Qian and Mur-
phy, 2011) of QpX, Aq “ EpY |X, Aq on p1,X, A,AXq and the corresponding estimated ITRpdpxq P argminaPt˘1u pQnpx, aq; 3) the standard ITR; 4) the RCT-DR-ITR for the calibrating Sce-
nario 1; and 5) the CTE-DR-ITR for the calibrating Scenario 2. We compare the testing values
EntestrCpXqpdpXqs based on an independent testing dataset of size ntest “ 100, 000 for every testing
distribution. The testing values across different testing distributions are not comparable. For a
specific testing distribution, the LB-ITR can be a benchmark to be compared to, since its testing
value is the best achievable in theory among the linear ITR class. The training-calibrating-testing
procedure is replicated for 500 times. The testing values (standard errors) for ncalib “ 50 are
reported in Table 2.
When the testing distribution is the same as training pµ1, µ2q “ p0, 0q, the calibration procedures
for the DR-ITRs are expected to choose c “ 1, which corresponds to the standard ITR. With the
finite calibrating sample, some DR-constant c greater than 1 can be possibly chosen, leading to
smaller testing values for the DR-ITRs in Table 2. In particular, the testing value of the CTE-
DR-ITR is higher than that of the RCT-DR-ITR, and is closer to the testing value of the standard
ITR in this case. The reason is that, the RCT-based calibrating value function estimate pVIPWEcalib
depends on pX, A, Y q in the calibrating data, while the CTE-based one pVCTEcalib depends on X only.
As a consequence, the CTE-based calibration can be more accurate than the RCT-based one.
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Table 2: Testing Values (Standard Errors) on the Mean-Shifted Covariate Domains (ncalib “ 50)
µ2
µ1
type 0 0.734 1.469 1.958
LB-ITR 2.333 (0.00244) 2.907 (0.011) 5.334 (0.0362) 9.27 (0.0154)
`1-PLS 2.124 (0.0022) 2.235 (0.011) 3.613 (0.0505) 6.32 (0.103)
Standard ITR 2.089 (0.00158) 1.735 (0.013) 1.348 (0.0595) 1.567 (0.13)
RCT-DR-ITR 2.085 (0.00444) 2.286 (0.0114) 4.545 (0.0255) 8.371 (0.0451)
1.958
CTE-DR-ITR 2.098 (0.00348) 2.304 (0.0106) 4.551 (0.0238) 8.459 (0.0424)
LB-ITR 1.893 (0.00712) 2.627 (0.00656) 5.28 (0.0213) 9.379 (0.0128)
`1-PLS 1.667 (0.00307) 2.021 (0.0076) 4.095 (0.0342) 7.573 (0.0706)
Standard ITR 1.674 (0.00152) 1.645 (0.0127) 2.377 (0.0553) 4.011 (0.119)
RCT-DR-ITR 1.627 (0.00688) 1.987 (0.00997) 4.484 (0.0192) 8.611 (0.0285)
1.469
CTE-DR-ITR 1.663 (0.00326) 1.997 (0.00992) 4.55 (0.0163) 8.686 (0.0269)
LB-ITR 1.227 (0.00244) 2.144 (0.00609) 5.269 (0.00931) 9.608 (0.00898)
`1-PLS 1.094 (0.00418) 1.676 (0.00442) 4.587 (0.0151) 8.8 (0.0314)
Standard ITR 1.174 (0.00149) 1.553 (0.00806) 3.739 (0.0379) 7.06 (0.0763)
RCT-DR-ITR 1.094 (0.00753) 1.651 (0.00675) 4.622 (0.0109) 9.036 (0.015)
0.734
CTE-DR-ITR 1.152 (0.00292) 1.667 (0.00588) 4.648 (0.0113) 9.06 (0.0161)
LB-ITR 0.9942 (0.00202) 1.774 (0.0034) 5.232 (0.00559) 9.767 (0.0068)
`1-PLS 0.8296 (0.00454) 1.648 (0.0036) 4.914 (0.00501) 9.476 (0.0103)
Standard ITR 0.9437 (0.00153) 1.679 (0.00336) 4.654 (0.017) 8.895 (0.0342)
RCT-DR-ITR 0.8374 (0.00821) 1.647 (0.00574) 4.868 (0.00797) 9.444 (0.00841)
0.000
CTE-DR-ITR 0.9206 (0.00272) 1.688 (0.00289) 4.888 (0.00698) 9.442 (0.00999)
1 µ “ pµ1, µ2, 0, ¨ ¨ ¨ , 0qᵀ with µ1 in column and µ2 in row is the testing covariate centroid.
2 Values (larger the better) can be comparable for the same pµ1, µ2q but incomparable across different pµ1, µ2q.
3 LB-ITR maximizes the testing value function at pµ1, µ2q over the linear ITR class. The corresponding testing value is the
best achievable among the linear ITR class.
When pµ1, µ2q ‰ p0, 0q, the testing distribution is different from training, and the performance of
the standard ITR deteriorates while the DR-ITRs still maintain reasonably good performance. The
phenomenon is more evident when µ1, µ2 P t1.469, 1.958u. In particular at pµ1, µ2q “ p1.958, 1.958q,
the value of the standard ITR can be as low as 17% of the best achievable value among the linear
ITR class, while the DR-ITRs can maintain more than 90%. In fact, such a phenomenon is
general. In Figure 3a, we further enumerate the testing covariate centroid µ “ pµ1, µ2, 0, ¨ ¨ ¨ , 0qᵀ
for µ1, µ2 P r´2.448, 2.448s and compute the relative regrets of the standard ITR and the RCT-DR-
ITR. Across all mean-shifted testing distributions, the relative regrets of the standard ITRs can be
as high as 108%, in which case the standard ITR value is negative, and hence even worse than the
completely random treatment rule drand. On the contrary, the relative regrets for the RCT-DR-ITR
(ncalib “ 50) shown in Figure 3b are at most 24% across all testing centroids. This suggests that
the RCT-DR-ITR maintains relatively good performance on all such testing distributions, while
the standard ITR fails. Figure 4 further shows that the DR-ITR provides substantial testing value
improvements over the standard ITR. This demonstrates that the small sample size ncalib “ 50 is
sufficient for calibrating the DR-ITR with significant testing improvement.
From Table 2, it can be also observed that `1-PLS can have better performance than the standard
ITR when training and testing distributions are different. The reason is that, the objective of `1-
PLS does not target the value function under the training distribution directly, but rather, the
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mean squared error of the linear approximation to QpX, Aq under the training distribution. Such
a linear approximation can perform well when the testing distribution is not far from the training
distribution. However, in the case µ1, µ2 P t1.469, 1.958u in the sense that the testing distribution
deviates more from the training one, the DR-ITRs enjoy notably higher testing values than `1-PLS.
In the Supplementary Material, we provide more detailed results for other comparisons in-
cluding the relative regrets/improvements on all mean-shifted covariate domains of all centroids,
the misclassification rates on all mean-shifted covariate domains of all centroids, the compar-
ison with some other methods in relative regrets and misclassification rates, and the case of
k P t1.25, 1.5, 2, 3,8u. In particular, the misclassification rates inform similar conclusions as the
relative regrets/improvements. If we increase the calibrating sample size from 50 to 100, then
the testing values of DR-ITRs can be further improved. We also find that among our simulation
scenarios, the testing values of the DR-ITR are not very sensitive to difference choices of k.
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Figure 3: Relative Regrets on the Mean-Shifted Covariate Domains (lighter the better).
4.2 Performance on the Mixture of Subgroups
In this section, we consider a population that consists of two subgroups, with each following a
distinct CTE function. We aim to find an ITR that can generalize well on different mixtures of
subgroups.
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Figure 4: Relative improvements of the RCT-DR-ITR over the standard ITR as the difference of their
relative regrets on the mean-shifted covariate domains (ncalib “ 50, darker the better).
We modify the simulation setup in Section 4.1 as follows: X|ξ „ ξNppµ1, Ipq`p1´ξqNppµ0, Ipq,
where ξ „ Bernoullippmixq is the unobservable mixture/subgroup indicator with subgroup 1 proba-
bility pmix and subgroup 0 probability 1´pmix, and the subgroup means µ1 “ p´1{2, 1{2, 0, ¨ ¨ ¨ , 0qᵀ
and µ0 “ ´µ1. We consider the CTE function Cpx; ξq :“ p2ξ ´ 1qβ0 ` β1x1 ` β2x2 that is linear
in the covariate vector, but with a subgroup-dependent intercept p2ξ ´ 1qβ0, and pβ0, β1, β2q :“
p´3{2,´2, 1q. The unconditional CTE function is nonlinear:
Cpxq :“ ErCpx; ξq|X “ xs “ pmix expp´}x´ µ1}
2
2{2q ´ p1´ pmixq expp´}x´ µ0}22{2q
pmix expp´}x´ µ1}22{2q ` p1´ pmixq expp´}x´ µ0}22{2q
β0`β1x1`β2x2.
In particular, the unconditional CTE function Cpxq depends on the subgroup 1 probability pmix.
The distributional changes are due to the subgroup 1 probability. Specifically, the training subgroup
1 probability is 0.75, while the testing subgroup 1 probability varies in t0.1, 0.25, 0.5, 0.75, 0.9u.
Since the training and testing CTE functions can be different, Assumption 1 cannot be fully met.
Therefore, our proposed DR-ITR can be robust to such distributional changes only to some extent.
We consider the same training-calibrating-testing procedure as that in Section 4.1, except that
the DR-constant c ranges in t1.18, 1.27, ¨ ¨ ¨ , 10u. The testing values of the ITRs are reported in
Table 3. When the training and testing distributions are the same at pmix “ 0.75, all ITRs have
similar testing performance. The standard ITRs have higher testing values than the DR-ITRs in this
case. When the testing pmix becomes smaller, the DR-ITRs show better testing performance than
24
the standard ITR. When the testing pmix “ 0.25 or 0.1, the RCT-DR-ITR has the highest testing
values among all. Since the true testing CTE function changes along with the testing pmix, the
corresponding estimate pCn based on the training data can suffer from the generalizability problem.
Therefore, the CTE-based calibration performs slightly worse than the RCT-based calibration in
this case. However, the CTE-based DR-ITR is superior to the standard ITR, and is comparable to
the `1-PLS. More detailed comparisons and the case ncalib “ 100 are provided in the Supplementary
Material.
Table 3: Testing Values (Standard Errors) on the Mixture of Subgroups (ncalib “ 50)
Testing Subgroup 1 Probability
type 0.1 0.25 0.5 0.75 0.9
LB-ITR 1.665 (0.0067) 1.537 (0.00618) 1.444 (0.00412) 1.545 (0.00537) 1.679 (0.00585)
`1-PLS 1.182 (0.00191) 1.264 (0.0014) 1.399 (0.000591) 1.537 (0.000333) 1.624 (0.000781)
Standard ITR 1.143 (0.00434) 1.232 (0.00329) 1.383 (0.0015) 1.535 (0.000543) 1.632 (0.00142)
RCT-DR-ITR 1.267 (0.0066) 1.305 (0.00423) 1.395 (0.00256) 1.52 (0.00212) 1.614 (0.00234)
CTE-DR-ITR 1.16 (0.00409) 1.247 (0.00323) 1.388 (0.00137) 1.534 (0.00055) 1.628 (0.00149)
1 Testing subgroup 1 probability = 0.75 is the same as the training one.
2 Values (larger the better) can be comparable for the same subgroup 1 probability but incomparable across different subgroup
1 probabilities
3 LB-ITR maximizes the testing value function over the linear ITR class. The corresponding testing value is the best achievable
among the linear ITR class.
5 Application to the ACTG 175 Trial Data
In this section, we evaluate the generalizability of our proposed DR-ITR on a clinical trial dataset
from the “AIDS clinical trial group study 175” (Hammer et al., 1996). The goal of this study was
to compare four treatment arms among 2,139 randomly assigned subjects with human immunode-
ficiency virus type 1 (HIV-1), whose CD4 counts were 200-500 cells/mm3. The four treatments are
the zidovudine (ZDV) monotherapy, the didanosine (ddI) monotherapy, the ZDV combined with
ddI, and the ZDV combined with zalcitabine (ZAL).
The evidence found from the AIDS trial data can have some generalizability problems. When
studying women living with HIV and women at risk for HIV infection in the USA cohort, the
Women’s Interagency HIV Study (WIHS) (Bacon et al., 2005) has been considered to be represen-
tative. However, it was reported in Gandhi et al. (2005) that 28-68% of the HIV positive women in
WIHS were excluded from the eligibility criteria of many ACTG studies. In the ACTG 175 dataset,
the number of female patients is only 368 out of 2139. Thus we suspect that the female patients
may be underrepresented in this dataset, and the ITR based on the dataset may not generalize
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well on the women subgroup. In this section, we study the generalizability of DR-ITR when the
testing dataset consists of female patients only. Specifically, the training dataset is a subsample
from ACTG 175 with original male/female proportion, while the testing dataset is a subsample
from the female patients of ACTG 175, and there is no overlap across training and testing. We try
to resemble the ideal world that we can have independent testing data from the female population.
We consider the outcome Y as the difference between the early stage (at 20˘5 weeks from
baseline) CD4 cell counts and the CD4 counts at baseline. We focus on the treatment comparison
between the ZDV + ZAL (A “ 1) and the ddI (A “ ´1), and the corresponding patients from the
dataset. In particular, only 180 of them are women. The average treatment effects on the male and
female subgroups are ´8.97 and ´1.39 respectively, which suggests that there is treatment effect
discrepancy between these subgroups. We sample the training data from the ACTG 175 dataset
in the ZDV + ZAL or ddI arm of sample size 1, 085 ˆ 60% “ 651 stratified to the gender. In
particular, the training dataset includes 180 ˆ 60% “ 108 female patients. The remaining female
data p180´ 108 “ 72q are used for testing. We only consider female patients in testing. We further
sample 50 from the testing female data for calibration, and the remaining p72 ´ 50 “ 22q are the
testing dataset. We also consider 12 selected baseline covariates X as was studied in Lu et al.
(2013). There are 5 continuous covariates: age (year), weight (kg, coded as wtkg), CD4 count
(cells/mm3) at baseline, Karnofsky score (scale of 0-100, coded as karnof), CD8 count (cells/mm3)
at baseline. They are centered and scaled before further analysis. In addition, there are 7 binary
variables: gender (1 = male, 0 = female), homosexual activity (homo, 1 = yes, 0 = no), race (1 =
nonwhite, 0 = white), history of intravenous drug use (drug, 1 = yes, 0 = no), symptomatic status
(symptom, 1 = symptomatic, 0 = asymptomatic), antiretroviral history (str2, 1 = experienced, 0
= naive) and hemophilia (hemo, 1 = yes, 0 = no).
Before fitting ITRs, we estimate the CTE function CpXq by the following regress-and-subtract
procedure: first we fit two separate random forests by regressing Y on X restricted on A “ 1
and A “ ´1 respectively; then we subtract two regression models to obtain the CTE function
estimate pCnpXq. We follow the same implementation as in Section 4.1 to fit the standard ITR
and DR-ITRs over a constrained linear function class Fγ :“ tfpxq “ b ` βᵀx : b P R, β P
Rp, }β}2 ď γu on the training data. The testing performance is evaluated by the IPWE of
the value function on the testing data. The training-calibrating-testing procedure is repeated
for 1,500 times. The testing values are reported in Table 4, where the value can be interpreted
as the expected CD4 count improvement from baseline at the early stage (20 ˘ 5 weeks). In
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addition to the calibrated DR-ITRs, we also include the value of the best DR-ITR that enjoys
the highest testing performance among all DR-constants. For comparison, we include the results
of residual weighted learning (RWL) (Zhou et al., 2017) with linear kernel. Both RWL and the
standard ITR share similar implementation, except that RWL can be shown equivalently usingpCnpXq “ pQnpX, 1q ´ pQnpX,´1q ` 2ArY ´ pQnpX, Aqs as a plug-in CTE estimate.
The testing results show that our proposed DR-ITRs can have better values than the standard
ITR and RWL. In particular, the improvement of the best DR-ITR is substantial, while the im-
provements of the calibrated ITRs are not as strong. We plot the testing values of the DR-ITRs
against the corresponding DR-constants in Figure 5. It suggests that the testing values generally
increase with the DR-constant. In this analysis, the calibrated DR-constants are not close to the
optimal DR-constant. As a result, the testing performance of the calibrated DR-ITRs is not as
good as the best DR-ITR. One reason for this phenomenon can be that the outcome Y has a heavy
tail distribution, as was highlighted in Qi et al. (2019b), so that the value function estimate is
highly variable based on the small calibrating sample. Another reason can be that the random
forest regress-and-subtract estimate of the CTE function does not generalize well on the testing
distribution.
Table 4: Expected CD4 Count Improvement (cells/mm3) from Baseline at the Early Stage (20˘5
weeks) and Standard Errors on the ACTG-175 Female Patients (higher the better).
RWL Standard ITR Best DR-ITR RCT-DR-ITR CTE-DR-ITR
10.7617 (0.8636) 10.593 (0.8627) 13.9423 (0.8378) 11.8133 (0.8357) 11.1563 (0.8514)
Standard errors are computed based on 1,500 replications.
On the overall dataset, we fit the DR-ITRs and report their fitted coefficients in Table 5 for
selected DR-constants. To stabilize the randomness from the random forest estimate of the CTE
function, we refit the random forest 20 times and average the corresponding DR-ITR coefficients.
We find that there are noticeable changes in the coefficients of the intercept and the homosexual
activity when the DR-constant gets large. Within the ACTG 175 dataset (ZDV + ZAL or ddI),
we find that only 6 female patients have homosexual activity. Four of them are treated with ZDV
+ ZAL, and the change of their CD4 counts are 123, 34, ´11 and 158 respectively. Two of them
are treated with ddI, and the change of their CD4 counts are ´41, ´182. Therefore, the ZDV +
ZAL (A “ `1) may have more benefits compared to the ddI pA “ ´1q on these patients. This
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Figure 5: Expected CD4 Count Improvement (cells/mm3) from Baseline at the Early Stage (20˘5 weeks)
of the DR-ITRs of Various DR-Constants on the ACTG 175 Female Patients (higher the better)
helps to explain why the larger coefficients in homosexual activity for the larger DR-constants can
be beneficial for the female patients.
Table 5: Linear Coefficients of the DR-ITRs Fitted on the ACTG 175 Dataset
DR-
constant
Intercept age wtkg cd40 karnof cd80 gender homo race drugs symptom str2 hemo
1 ´0.02 ´0.25 0.06 ´0.58 ´0.06 0.53 ´0.16 ´0.4 0.16 0.16 0.16 0.16 0.09
4.8 ´0.31 ´0.23 0.12 ´0.67 0.11 0.55 ´0.12 ´0.21 0.2 0.12 0.1 ´0.06 0.09
8.6 ´0.43 ´0.23 0.11 ´0.64 0.16 0.54 ´0.11 ´0.05 0.12 0.04 0.07 ´0.24 0.01
12.4 ´0.54 ´0.22 0.1 ´0.64 0.19 0.51 ´0.04 0.01 0.08 0.05 0.04 ´0.27 ´0.02
16.2 ´0.61 ´0.23 0.1 ´0.64 0.2 0.51 0 0.03 0.06 0.05 0.02 ´0.27 ´0.02
20 ´0.64 ´0.24 0.09 ´0.63 0.22 0.5 0.01 0.03 0.05 0.07 0.01 ´0.26 ´0.01
1 DR-constant = 1 corresponds to the standard ITR; DR-constant = 16.2 has the highest testing value in Figure 5.
6 Discussion
In this paper, we propose a new framework for learning a distributionally robust ITR by maximiz-
ing the worst-case value function among values under distributions within the power uncertainty
set. We introduce two possible calibration scenarios under which the DR-constant can be tuned
adaptively to a small amount of the calibrating data from the target population. In this way,
when the training and testing distributions are identical, the calibrated DR-ITRs can achieve sim-
ilar performance as compared to the standard ITR. When the testing distribution deviates from
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the training distribution, we show that there are many possible scenarios that the standard ITR
generalizes poorly, while the calibrated DR-ITRs maintain relatively good testing performance.
Our simulation studies and an application to the ACTG 175 dataset demonstrate the competitive
generalizability of our proposed DR-ITR.
The main assumption on the changes of covariates in our DR-ITR framework is equivalent to
the selection unconfoundedness assumption in a randomized controlled trial. In practice, there
may exist unmeasured selection confounding problems for the trial data, and the distributional
changes affect both the covariates and the CTE function. One possible extension is to consider
the simultaneous changes of the covariate distribution and the CTE function, and leverage more
general robustness measure against these changes.
In our DR-ITR framework, we require an estimate of the CTE function based on the flexible
nonparametric techniques. The performance of our DR-ITR can depend on the quality of the CTE
function estimate. An alternative strategy is to avoid plugging in a CTE estimate. Instead, the
dual representation (10) can be identified from pX, A, Y q directly using a variational representation
of r˘CpXq ´ ηsk‹` (Duchi et al., 2019). This can be a possible extension of our framework.
Another possible extension is to consider the problem of high-dimensional covariates. Our
current formulation involves an `2-constraint to control the model complexity. It can be extended
to obtain sparse solutions when a `1-constraint is used instead. Besides the high-dimensional
extension, our current theoretical results assume that CpXq is uniformly bounded. It will be
interesting to relax the assumption, such as sub-Gaussianity. Further investigations along these
lines can be pursued.
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